-+ 0.00%
-+ 0.00%
-+ 0.00%

Achieve Life Sciences files Form 3 initial beneficial ownership for TPG GP A LLC

PUBT·04/24/2026 21:04:23
Listen to the news
Achieve Life Sciences files Form 3 initial beneficial ownership for TPG GP A LLC
  • Achieve Life Sciences Form 3 filing showed TPG GP A reported 6,877,580 shares of common stock held indirectly, tied to TPG LSI Rise Auriga.
  • Filing also reported 6,877,580 warrants exercisable for common stock at USD 3.51 per share, exercisable any time after April 17, 2026.
  • Warrants expire on 20th business day following later of public announcement of FDA approval of cytisinicline for adult smoking cessation or notice of that approval.
  • Warrant terms include 19.99% beneficial ownership cap on exercise.
  • TPG GP A, James G. Coulter, Jon Winkelried were listed as reporting persons as 10% owners.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001999371-26-009035), on April 24, 2026, and is solely responsible for the information contained therein.